A Single Course of Anti-CD3 Monoclonal Antibody hOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes

• Published in: Diabetes (New York, N.Y.) Vol. 54; no. 6; pp. 1763 - 1769
• Main Authors: Herold, Kevan C., Gitelman, Stephen E., Masharani, Umesh, Hagopian, William, Bisikirska, Brygida, Donaldson, David, Rother, Kristina, Diamond, Beverly, Harlan, David M., Bluestone, Jeffrey A.
• Format: Journal Article
• Language: English
• Published: Alexandria, VA American Diabetes Association 01.06.2005
• Subjects: Biological and medical sciences; Diabetes. Impaired glucose tolerance; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Immunology and Transplantation; Medical sciences; Endocrinopathy; Immunopathology; Autoimmune disease; Monoclonal antibody; Type 1 diabetes; C-Peptide

A Single Course of Anti-CD3 Monoclonal Antibody hOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes Kevan C. Herold 1 , Stephen E. Gitelman 2 , Umesh Masharani 2 , William Hagopian 3 , Brygida Bisikirska 1 , David...